What is my risk of breast cancer?
Read about the factors you can and can't control.
What is my risk of breast cancer?
Everyone has some level of risk of breast cancer, but the good news is, you can take steps to reduce it. Understanding your personal risk factors is the first step toward prevention.
This guide breaks down the science in a clear, easy-to-understand way, explaining what influences your risk.
The factors you can't change.
Your risk of developing breast cancer is shaped by a combination of factors:
- Age: as you get older, your risk increases due to the accumulation of genetic mutations over time.
- Gender: being born female means higher lifetime exposure to oestrogens, which can stimulate cell growth in breast tissue.
- Breast density: high breast density is a risk factor. It’s partly genetic and can change over your lifetime.
- Ethnicity: black women from Caribbean and African backgrounds are up to two times more likely to receive a late-stage diagnosis for some cancers than white British women in England.
- Breast cancer history: a history of benign (non-cancerous) breast disease or previous breast cancer increases your risk.
- Reproductive history: starting your periods early (before 12) or reaching menopause late (after 55) means longer exposure to oestrogens.
- Physical traits: being tall, having a higher birth weight (above 4kg) or large early body size may increase risk, possibly due to higher levels of growth hormones.
- Higher levels of naturally circulating sex hormones (such as oestrogen) increase breast cancer risk.
Genetic factors:
- Some people inherit gene mutations, like BRCA1 or BRCA2; they are uncommon, but they do increase risk.
- If you have a family history of breast cancer (mother, sibling or daughter, especially at a young age), this approximately doubles your risk.
- Genetic variation in multiple genes and other regions of DNA is also associated with an increased breast cancer risk.
The factors you can influence.
- Any amount of alcohol increases risk. It's been shown to raise estrogen levels and can damage DNA.
- Regular physical activity helps to lower hormone levels, like estrogen, that are linked to cancer growth. Staying active is a simple but effective way to reduce your risk.
- A diet rich in fruits, vegetables, and fibre may help reduce your risk.
- Being overweight after menopause, mainly due to higher oestrogen levels, is also linked to increased risk.
- Having children at a younger age (before 30) and having more children younger can reduce your risk too.
- Breastfeeding can reduce your risk; the longer you do it, the larger the risk reduction.
- Smoking, especially if you start young or continue long-term, increases your risk.
- The combined pill slightly increases risk, however the risk is no longer evident after use has stopped for 10 years.
- Combined Hormone Replacement Therapy (HRT) can slightly increase your risk, especially with long-term use (over 5 years).
- Breast cancer is more common in high-income countries. In the UK, women in lower-income areas often face later diagnosis; this could be due to lower screening uptake and awareness, which affects outcomes.
Other risk factors.
Environment and chemical exposures:
- Pollution: breathing in polluted air, which contains harmful chemicals, may increase your risk.
- Everyday products: many common products may contain Endocrine Disrupting Chemicals (EDCs) that can mimic hormones and may increase breast cancer risk.
Medical and radiation:
- Radiation: high-energy radiation, like from certain medical treatments or nuclear fallout, especially during puberty, can damage your DNA and raise your risk.
- DES: if you or your mother were exposed to DES, a drug once used to prevent miscarriage, you may have a higher risk.
Next steps: Take our quiz to reduce your risk.
While not all risk factors are within your control, adopting healthier habits can make a significant difference. While you can't control everything, studies suggest that at least 30% of breast cancer cases could be prevented through lifestyle changes.
Take our short quiz, answer a few lifestyle questions and get your personalised action plan to help you reduce your risk of breast cancer.
Last review: Nov-25 | Next review: Jan-26.
-
{1} AICR, WCRF. Diet, nutrition, physical activity and breast cancer: a global perspective. Continuous Update Project Report. 2018. Available from: https://www.wcrf.org/wp-content/uploads/2021/02/Breast-cancer-report.pdf
{2} Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229–63. https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21834.
{3} Brown SB, Hankinson SE. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers. Steroids [Internet]. 2015 Jul 1 [cited 2023 Aug 7];99(Pt A):8–10. Available from: https://pubmed.ncbi.nlm.nih.gov/25555473/
{4} Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. British Journal of Cancer 2018 118:8 [Internet]. 2018 Mar 23 [cited 2023 Jul 28];118(8):1130–41. Available from: https://www.nature.com/articles/s41416-018-0029-6
{5} Cancer Australia. Risk factors for breast cancer: A review of the evidence. Surry Hills, NSW; 2018. Available from: https://www.canceraustralia.gov.au/publications-and-resources/cancer-australia-publications/risk-factors-breast-cancer-review-evidence-2018
{6} Cancer Research UK. (2020). Cancer in the UK 2020: Socio-economic deprivation. https://bsw.icb.nhs.uk/wp-content/uploads/sites/6/2022/06/cancer_inequalities_in_the_uk-1.pdf.
{7} Cancer Research UK. (2023). Family History of breast cancer and inherited genes. https://www.cancerresearchuk.org/about-cancer/breast-cancer/risks-causes/family-history-and-inherited-genes
{8} Colditz GA, Bohlke K. Priorities for the primary prevention of breast cancer. CA Cancer J Clin [Internet]. 2014 May [cited 2023 Aug 7];64(3):186–94. Available from: https://pubmed.ncbi.nlm.nih.gov/24647877/
{9} Cordina-Duverger E, Menegaux F, Popa A, Rabstein S, Harth V, Pesch B, et al. Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history. Eur J Epidemiol [Internet]. 2018 Apr 1 [cited 2023 Aug 7];33(4):369–79. Available from: https://pubmed.ncbi.nlm.nih.gov/29464445/
{10} Farvid MS, Sidahmed E, Spence ND, Mante Angua K, Rosner BA, Barnett JB. Consumption of red meat and processed meat and cancer incidence: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol 2021;36:937–51. https://link.springer.com/article/10.1007/s10654-021-00741-9.
{11} Farvid MS, Spence ND, Holmes MD, Barnett JB. Fiber consumption and breast cancer incidence: A systematic review and meta‐analysis of prospective studies. Cancer 2020;126:3061–75. https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32816.
{12} Gathani T, Ali R, Balkwill A, Green J, Reeves G, Beral V, et al. Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study. Br J Cancer 2014;110:224–9. https://www.nature.com/articles/bjc2013632.
{13} Green, S. M. C., Lloyd, K. E., & Smith, S. G. (2023). Awareness of symptoms, anticipated barriers and delays to help-seeking among women at higher risk of breast cancer: A UK multicentre study. Preventive Medicine Reports, 34, 102220. https://www.sciencedirect.com/science/article/pii/S2211335523001110?via%3Dihub
{14} Group on Hormonal Factors in Breast Cancer C. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet [Internet]. 2019 Sep 28 [cited 2023 Jul 3];394(10204):1159–68. Available from: http://www.thelancet.com/article/S014067361931709X/fulltext
{15} Hirko KA, Rocque G, Reasor E, Taye A, Daly A, Cutress RI, et al. The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology. BMC Med 2022;20:72. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-022-02260-0.
{16} Huo CW, Chew GL, Britt KL, Ingman W V., Henderson MA, Hopper JL, et al. Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat [Internet]. 2014 [cited 2023 Aug 7];144(3):479–502. Available from: https://pubmed.ncbi.nlm.nih.gov/24615497/
{17} Jishi T, Sergi C. Current perspective of diethylstilbestrol (DES) exposure in mothers and offspring. Reproductive Toxicology. 2017 Aug 1;71:71–7. https://www.sciencedirect.com/science/article/abs/pii/S089062381730223X?via%3Dihub.
{18} Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA 2017;317:2402. https://doi.org/10.1001/jama.2017.7112.
{19} Lyratzopoulos, G., Abel, G. A., Brown, C. H., Rous, B. A., Vernon, S. A., Roland, M., & Greenberg, D. C. (2013). Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Annals of Oncology, 24(3), 843–850. https://doi.org/10.1093/annonc/mds526
{2} Rodgers KM, Udesky JO, Rudel RA, Brody JG. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms. Environ Res [Internet]. 2018 [cited 2023 Aug 7];160:152–82. Available from: https://pubmed.ncbi.nlm.nih.gov/28987728/
{21} Shin S, Fu J, Shin W-K, Huang D, Min S, Kang D. Association of food groups and dietary pattern with breast cancer risk: A systematic review and meta-analysis. Clinical Nutrition 2023;42:282–97. https://www.clinicalnutritionjournal.com/article/S0261-5614(23)00005-5/abstract.
{22} Shirley MH, Barnes I, Sayeed S, Finlayson A, Ali R. Incidence of breast and gynaecological cancers by ethnic group in England, 2001–2007: a descriptive study. BMC Cancer 2014;14:979. https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-979.
{23} Soerjomataram I, Shield K, Marant-Micallef C, Vignat J, Hill C, Rogel A, et al. Cancers related to lifestyle and environmental factors in France in 2015. Eur J Cancer [Internet]. 2018 Dec 1 [cited 2023 Aug 7];105:103–13. Available from: https://pubmed.ncbi.nlm.nih.gov/30445359/
{24} Tin Tin S, Reeves GK, Key TJ. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. Br J Cancer [Internet]. 2021 Jul 6 [cited 2023 Aug 7];125(1):126–34. Available from: https://pubmed.ncbi.nlm.nih.gov/33864017/
{25} Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ 2020:m3873. https://www.bmj.com/content/371/bmj.m3873.
{26} White AJ, Bradshaw PT, Hamra GB. Air pollution and Breast Cancer: A Review. Curr Epidemiol Rep [Internet]. 2018 Jun [cited 2023 Aug 7];5(2):92–100. Available from: https://pubmed.ncbi.nlm.nih.gov/30271702/